Rising Preference for Urine Specimens for Drug Abuse Testing Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/drug-of-abuse-testing/report-sample Testing for drugs of abuse (DOA) is a clinical screening method for identifying one or more unlawful substances, such as drugs, chemicals, or plant products. This clinical screening technique is carried out to determine whether any prescription or illicit medications are present in the patient's saliva, urine, hair, blood, or perspiration. P&S Intelligence says, by 2030, it is expected that the drug of abuse testing market would be worth USD 10,485.7 million. The increase is due to a number of factors, including rising rates of technical development and increased public awareness of the negative consequences of drugs and alcohol.